Tapinarof
Novo invests US$ 1.2 bn in new rare disease plant in Denmark; FDA approves two drugs for atopic dermatitis

Novo invests US$ 1.2 bn in new rare disease plant in Denmark; FDA approves two drugs for atopic dermatitis

As the year draws to a close, the US Food and Drug Administration (FDA) has been approving drugs at a feverish pace. It approve...

Impressions : 1010